Systematic Review of Recurrent Osteosarcoma Systemic Therapy
Osteosarcoma is the most frequent primary bone cancer, mainly affecting those of young ages. Although surgery combined with cytotoxic chemotherapy has significantly increased the chances of cure, recurrent and refractory disease still impose a tough therapeutic challenge. We performed a systematic l...
Main Authors: | Ioanna Gazouli, Anastasios Kyriazoglou, Ioannis Kotsantis, Maria Anastasiou, Anastasios Pantazopoulos, Maria Prevezanou, Ioannis Chatzidakis, Georgios Kavourakis, Panagiota Economopoulou, Vasileios Kontogeorgakos, Panayiotis Papagelopoulos, Amanda Psyrri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1757 |
Similar Items
-
Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
by: Panagiota Economopoulou, et al.
Published: (2020-11-01) -
A Review of T-Cell Related Therapy for Osteosarcoma
by: Kazushige Yoshida, et al.
Published: (2020-07-01) -
Special Issue about Head and Neck Cancers: HPV Positive Cancers
by: Panagiota Economopoulou, et al.
Published: (2020-05-01) -
Anti-angiogenetic agents against tumor types and cardiovascular risk
by: Panagiota Economopoulou, et al.
Published: (2017-05-01) -
De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Panagiota Economopoulou, et al.
Published: (2021-09-01)